The Patent Finder

Kato Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Kato Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 4 of 4 · Back to Kato Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 7,977,385Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
Term ended
Term ended Apr 7, 2021 · From the USPTO record
Term endedTerm ended Apr 7, 2021From the USPTO record
US 7,008,960Agents for intravitreal administration to treat or prevent disorders of the eye
Term ended
Term ended Oct 7, 2020 · From the USPTO record
Term endedTerm ended Oct 7, 2020From the USPTO record
US 6,462,071Agents for intravitreal administration to treat or prevent disorders of the eye
Term ended
Term ended Mar 2, 2020 · From the USPTO record
Term endedTerm ended Mar 2, 2020From the USPTO record
US 8,691,874Treatment of ophthalmic disorders using urea
Term ended
Ended no later than Mar 2, 2020 · From the USPTO record
Term endedEnded no later than Mar 2, 2020From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited